Kazerooni AF, Familiar AM, Aboian M, Brüningk SC, Vossough A, Linguraru MG, Huang RY, Hargrave D, Peet AC, Resnick AC, Storm PB, Mirsky D, Yeom KW, Weller M, Prados M, Chang SM, Mueller S, Villanueva-Meyer JE, Bakas S, Fangusaro J, Kann BH, Nabavizadeh A; Response Assessment in Pediatric Neuro-Oncology (RAPNO) group. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation , Lancet Oncol: 2025

Kann BH, Vossough A, Brüningk SC, Familiar AM, Aboian M, Linguraru MG, Yeom KW, Chang SM, Hargrave D, Mirsky D, Storm PB, Huang RY, Resnick AC, Weller M, Mueller S, Prados M, Peet AC, Villanueva-Meyer JE, Bakas S, Fangusaro J, Nabavizadeh A, Kazerooni AF; Response Assessment in Pediatric Neuro-Oncology (RAPNO) group. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art , Lancet Oncol: 2025

Madsen PJ, Schlitter AM, Flemmig C, Dickson C, Harvey K, Wilson C, Beaubien E, Patterson L, Stern A, Griffin C, Joshi N, Hajeebu S, Martinez D, Storm PB, Resnick AC, Hillemanns P, Stanulla M, Faber J, Wingerter A, Gaida MM, Holtemeyer S, Laible M, Feldner A, Frohns F, Duarte JH, Sinn BV, Wöll S, Sahin U, Türeci Ö, Foster JB. Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors , J Immunother Cancer, 13: 2025,e011709

Stern A, Jain A, Stein A, Storm PB, Rosenblum J, Pisapia JM. Targeted tumor resection to reestablish cerebrospinal fluid flow in the setting of a pediatric third ventricular glioma with obstructive hydrocephalus , Surg Neurol Int, 16: 2025,359

Foster JB, Madsen PJ, Harvey K, Griffin C, Stern A, Patterson L, Joshi N, Dickson C, McManus O, Beaubien E, Wilson C, Beale DR, Baubet V, Goel P PN, Vitanza NA, Nazarian J, Koptyra M, Storm PB, Resnick AC. Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models , Neuro Oncol: 2025

Kraya A, Rathi K, Jin R, Kesherwani V, Resnick AC, Storm PB, Nabavizadeh A. Evaluating the Potential of PSMA Targeting in CNS Tumors: Insights from Large-Scale Transcriptome Profiling , Cancers (Basel), 17: 2025,1239

Castellanos M, Lerner DK, Hamimi SA, Workman AD, Douglas JE, Kohanski MA, Storm PB, Palmer JN, Adappa ND. Safety and feasibility of the endoscopic endonasal approach to anterior skull base tumour resections in young children , Rhinology, 63: 2025,383-384

Corbett RJ, Kaufman RS, McQuaid SW, Vaksman Z, Phul S, Brown MA, Mason JL, Waszak SM, Zhang B, Zhong C, Desai H, Hausler R, Naqvi AS, Chroni A, Geng Z, Gonzalez EM, Zhu Y, Heath AP, Li M; Penn Medicine BioBank; Regeneron Genetics Center; Storm PB, Resnick AC, Maxwell KN, Cole KA, Waanders AJ, Bornhorst M, MacFarland SP, Rokita JL, Diskin SJ. Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors , medRxiv: 2025

Naqvi AS, Corbett RJ, Seghal P, Conkrite KL, Rathi KS, Ennis BM, Hayer KE, Zhang B, Brown MA, Miller DP, Kraya A, Coleman KL, Dybas JM, Geng Z, Blackden C, Arif S, Chroni A, Lahiri A, Hollawell ML, Storm PB, Haydar D, Foster JB, Koptyra M, Madsen PJ, Diskin SJ, Thomas-Tikhonenko A, Resnick AC, Rokita JL. Characterization of aberrant splicing in pediatric central nervous system tumors reveals CLK1 as a candidate oncogenic dependency , bioRxiv: 2025

Xu E, Zhang E, Park K, Ayub M, Zhao C, Huh JW, King JM, Paltin I, Shah AC, Storm PB, Tucker A, Madsen PJ, Lang SS. Medical management of cerebellar mutism syndrome at a quaternary children's hospital , Childs Nerv Syst, 41: 2025,100